Upgrade to SI Premium - Free Trial

Brainstorm Cell Therapeutics (BCLI) Tops Q2 EPS by 2c

August 13, 2015 8:49 AM

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q2 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

Categories

Earnings

Next Articles